BioIQ and Phosphorus Genomics Expand COVID-19 Testing Network with At-Home Saliva Test Kit
ATLANTA, June 17, 2020 — BioIQ, a healthcare engagement and clinical adherence technology platform company, and Phosphorus, a leading genomics firm headquartered in New York City with a laboratory in Secaucus, New Jersey, announced today a partnership to provide an EUA-authorized at-home test kit that enables individual users to self-collect COVID-19 testing samples for laboratory processing. The joint solution includes Phosphorus' easy-to-use, self-administered saliva collection kit and specimen return package, along with BioIQ's health technology platform to support digital symptom and exposure assessment, contact tracing, and follow-up care navigation. Test results are delivered within 24-48 hours of receipt of lab sample.